glp 1 covered by blue cross blue shield A handful of nonprofit and insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of Blue Cross Blue Shield of
Description
In addition to weight management, Wegovy is also approved to reduce the risk of heart attacks, strokes, and other cardiovascular events in people with obesity or who are overweight and have heart disease

10.1210/jc.2010-2081 26

Furthermore, augmented intraglomerular pressure induced by increased ANG II concentrations can promote further podocytes damage ensuring the formation of a feedback mechanism for ANG II synthesis, which is one of the key aspects of progressive glomerular disease (38)

Clinical evidence shows approximately 5070% of weight loss returns within 12 months after discontinuation for most patients
This isnt the finish line
